|
|
Volumn 4, Issue 1, 2002, Pages 20-28
|
|
Inhibition of vascular endothelial growth factor in the treatment of solid tumors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
ENDOTHELIAL CELL GROWTH FACTOR;
GROWTH FACTOR RECEPTOR;
LYMPHOKINE;
PROTEIN TYROSINE KINASE;
VASCULOTROPIN;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
ANIMAL;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG RESISTANCE;
HUMAN;
METABOLISM;
NEOPLASM;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUG RESISTANCE;
ENDOTHELIAL GROWTH FACTORS;
HUMANS;
LYMPHOKINES;
NEOPLASMS;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTORS, GROWTH FACTOR;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
|
EID: 0036134017
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-002-0044-9 Document Type: Review |
|
Times cited : (27)
|
|
References (138)
|
